SEATTLE, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2022 financial results on Thursday, October 7, 2021, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m.

SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: Morgan Stanley Virtual Global Healthcare Conference including a fireside chat

SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the 41st Annual Canaccord Genuity Growth Conference, including a presentation on Thursday, August 12, 2021 at 11:00 a.m.

Fiscal first quarter 2022 revenue of $59.5 million, a 66% increase compared to fiscal first quarter 2021 revenue of $35.9 million Company raises guidance for fiscal year 2022 to $300 million - $305 million, a 78% increase at the midpoint compared to fiscal year 2021 revenue of $170.4 million,

SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal first quarter 2022 financial results on Thursday, July 8, 2021, after the market closes.

Accolade to begin offering virtual primary care and mental health consultations directly to members. $200bn+ combined total addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and managing rising costs.

New board directors bring expertise in healthcare services, policy, and human resources SEATTLE , June 3, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company reinventing healthcare, today announced a series of changes to its board of directors that will bolster the board with significant

SEATTLE, June 01, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: The 41st Annual William Blair Growth Stock Conference, including a fireside

SEATTLE, May 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: The Bank of America 2021 Health Care Conference, including a presentation on

Fiscal fourth quarter 2021 revenue of $59.2 million , a 33% increase compared to fiscal fourth quarter 2020 revenue of $44.4 million  Fiscal year 2021 revenue of $170.4 million , a 29% increase compared to fiscal year 2020 revenue of $132.5 million  Initiates guidance for fiscal year 2022 revenue